Development Of Analysis Methods Based On Scientific Approach And Risk-Based Approach In The Pharmaceutical Industry: Narrative Review
Article Sidebar
Main Article Content
Abstract
The development of analytical methods and quality systems in the pharmaceutical industry is now shifting from the conventional trial and error approach to a systematic, scientific, and risk-based approach to meet international regulatory demands. This article aims to examine the effectiveness of implementing the concepts of Analytical Quality by Design (AQbD), Quality by Design (QbD), and various risk management instruments in improving product quality and operational efficiency in the pharmaceutical industry. Methods: This study is the result of a literature review of 15 scientific journals discussing analytical method development, process validation, product stability, and operational risk management. The analysis shows that the application of AQbD and QbD through parameters such as Analytical Target Profile (ATP) and Design of Experiments (DoE) can increase the robustness of analytical methods and reduce the risk of failures such as Out of Specification (OOS). The use of risk management tools such as Failure Mode and Effect Analysis (FMEA) has proven effective in identifying cross-contamination risks and distribution process failures. The integration of scientific and risk-based approaches has a significant positive impact in ensuring quality consistency, accelerating time-to-market, and supporting compliance with ICH guidelines (Q8, Q9, Q10, Q14).
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
References
Ambekar, R. K. C. dan N. (2025). A Comprehensive review of Analytical Quality by Design, ICH Q14, and Design of Experiments in Pharmaceutical Analysis: A Synergistic Paradigm for Enhanced Quality and Regulatory Efficiency. International Journal of Pharmacy & Life Sciences, 16(9), 18–26.
Azzahra, A. M., Studi, P., Apoteker, P., Farmasi, F., Farmasetika, D., & Farmasi, F. (2024). Penilaian Risiko menggunakan Metode Failure Mode and Effects Analysis ( FMEA ) terkait Kontaminasi Silang pada Area Pengemasan di Industri Farmasi “ XYZ ” Pengemasan sekunder di Industri “ XYZ ”. Pengemasan di industri farmasi “ XYZ ”. Penilaian risiko te. (5).
Das, P., & Maity, A. (2017). Analytical Quality by Design (AQbD) : A New Horizon For Robust Analytics in Pharmaceutical Process and Automation. International Journal of Pharmaceutics & Drug Analysis, 5(8), 324–337.
Demirel, G., Saray, D., Yaman, B., & Turkyilmaz, A. (2018). Quality By Design Approach for an Orally Disintegrating Tablet Analytical Method Validation. International Journal of Pharmaceutical Sciences and Drug Research, 10(1), 12–19. https://doi.org/10.25004/ijpsdr.2018.100103
Dewi, M., Pratama, R., Arifka, M., & Chaerunisaa, A. (2022). Quality By Design: Approach to Analytical Method Validation. Sciences of Pharmacy, 1(1), 38–46. https://doi.org/10.58920/sciphar01010033
Fitrio, Y. (2019). Case Study Risk Based Approach for Life Cycle Computerized System in Pharmaceutical Industry. Journal of Applied Information, Communication and Technology, 6(2), 61–73. https://doi.org/10.33555/ejaict.v6i2.66
Harahap, I., Maharani, I., Sitompul, L., & Hasibuan, M. F. (2026). Essentia : Journal of Medical Practice and Research Stabilitas Obat dalam Pengembangan Produk Farmasi : Tinjauan Berdasarkan Pedoman International Council for Harmonisation ( ICH ). 2(1).
Mahapatra, A. (2022). Approach of analytical quality by design and regulatory need. 6(April), 2572–2592.
Musyaffa, H. A., Roestan, M. R., & Nurrasjid, E. S. (2024). Kajian Risiko pada Proses Penyimpanan dan Pendistribusian Bahan Baku di Gudang Industri Farmasi dengan Pendekatan Metode Failure Mode and Effect Analysis Program Studi Profesi Apoteker , Fakultas Farmasi , Universitas Padjadjaran , Indonesia PT Bio Farma. Jurnal Ilmu Kesehatan Dan Gizi, 2(3), 202–211.
Pharmacopia, S. (2024). Oikonomia.
Rusdiana, D., & Fitra, O. A. (2023). Artikel Penelitian Analisa Manajemen Resiko Laboratorium Farmasetika Untuk Persyaratan ISO 9001 : 2015 Menggunakan Metode 5 Why Analysis Keywords : Laboratorium ; Risk ; 5 Why Analysis ; Kata Kunci : Laboratorium ; Resiko ; Metode 5Why ; Jurnal Farmasi Indonesia, IV(1), 41–47.
Sinuraya, M. J. &. (2010). Farmaka Farmaka. 16, 213–221.
Susendi, N., Suparman, A., & Sopyan, I. (2021). Kajian Metode Root Cause Analysis yang Digunakan dalam Manajemen Risiko di Industri Farmasi. Majalah Farmasetika, 6(4), 310. https://doi.org/10.24198/mfarmasetika.v6i4.35053
Testas, M., da Cunha Sais, T., Medinilha, L. P., Niwa, K. N. I., de Carvalho, L. S., Maia, S. D., Flores, A., Braz, L. P., Menezes, J. C., & Yamakawa, C. Y. (2021). An industrial case study: QbD to accelerate time-to-market of a drug product. AAPS Open, 7(1). https://doi.org/10.1186/s41120-021-00047-w
Thorat, V., Alave, S., & Bagul, V. (2026). Analytical quality by design ( AQbD ) approach for the simultaneous quantification of FDC in a cardiovascular drug by RP ‑ HPLC method.